Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in PD-(L)1-Monotherapy Pretreated, Advanced Non-Small Cell Lung Cancer: Results From a Phase 1b Clinical Trial.

Edward B Garon,Alexander I Spira,Sarah B Goldberg,Jamie E Chaft,Vassiliki Papadimitrakopoulou,Tina Cascone,Scott J Antonia,Julie R Brahmer,D Ross Camidge,John D Powderly,Antoinette J Wozniak, Enriqueta Felip, Song Wu,Maria L Ascierto,Nairouz Elgeioushi,Mark M Awad

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer（2023）

Cited 0|Views20
No score
Abstract
Durvalumab plus tremelimumab had a manageable safety profile, but the combination did not show efficacy following PD-(L)1 treatment failure.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined